Navigation Links
Operating Room Nurses are Concerned about Complications Associated with Powdered Gloves
Date:4/7/2008

tion fully understand the facts supported by evidence-based literature is essential to making a wise decision for the long-term," said Twomey.

Molnlycke Health Care provides healthcare facilities with a unique team approach that results in tailored, well-rounded glove solutions. This includes a full-line of powder-free, low-protein latex and non-latex glove styles to address all specialty needs. As reported in The Cochrane Review, the Biogel patented, puncture indication glove system (in either latex or non-latex) provides protection and an alert system for barrier breach which increases practitioner safety.(xiv)

Biogel gloves are manufactured by the only major surgical glove company with an exclusively powder-free surgical glove line, and are made from high-tech material that is bonded with a thin inner coating of acrylate terpolymer. The smooth inner surface allows Biogel gloves to be easily donned with damp or dry hands without the need for a powder lubricant.

About Molnlycke Health Care US, LLC

Molnlycke Health Care U.S., LLC, consists of two divisions -- Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.

i American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and Immunology (AAAAI). Joint Statement Concerning the Use of Powdered and Non-powdered Natural Rubber Latex Gloves, July 21, 1997.

ii Renz H, Gemsa D. Effects
'/>"/>

SOURCE Biogel
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Mylan Appoints Heather Bresch as Chief Operating Officer
2. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results
5. Creative Technology Services Creates a New Operating Company Focused on Mobility
6. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
7. AEterna Zentaris to Announce Third Quarter 2007 Financial and Operating Results on November 7, 2007
8. DATATRAK International Management To Host Conference Call on November 8, 2007 To Discuss Third Quarter and Nine Month Operating Results for 2007
9. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
10. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
11. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Arizona ... College (MCC) is celebrating National Manufacturing Day by opening ... enhanced machining, processing and additive manufacturing labs will be ... 3, 2014 at MCC’s Southern and Dobson campus (1833 ... in southeast Lot D. , The AzAMI at MCC ...
(Date:9/20/2014)... Nevada (PRWEB) September 20, 2014 ... extremely successful showing at the PAIN Week conference ... Cosmopolitan Hotel and Casino in Las Vegas from ... MarijuanaDoctors.com primarily attended PAIN Week in the hopes ... as a viable and legitimate tool to treat ...
(Date:9/19/2014)... 20, 2014 Consistent premium price ... the Vision Insurance industry in recent years; however, ... of industry margins. From 2009 to 2014, industry ... provide coverage for routine eye exams and other ... contact lens and refractive surgery. According to IBISWorld ...
(Date:9/19/2014)... September 19, 2014 Unbound , an ... families in regions of the Philippines being affected by both ... than 1,060 families evacuated to the nearest public schools while ... heavy rain and gusty winds to portions of the northern ... flooding. Some homes filled with more than 10 feet of ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... PR News at the Platinum PR and Top Places ... Hyatt in New York City. Camino received honorable mentions ... Shoestring Campaign” — for its work elevating Latina voices ... this incredible organization and be a part of its ...
Breaking Medicine News(10 mins):Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Vision Insurance in the US Industry Market Research Report from IBISWorld Has Been Updated 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2
... (Nasdaq: GTIV ), a leading provider of comprehensive home,health ... conferences hosted by Oppenheimer & Co., Credit Suisse and,Stephens Inc., ... -- 1:20 p.m. to 1:55 p.m. ET, Monday, November ... & Co. 19th Annual Healthcare Conference in New York. ...
... SGP ) said today that it strongly ... Missouri related to reimbursement by,Missouri,s Medicaid program of ... generics subsidiary, was incorrect.,The company said it will ... all applicable laws and regulations governing reimbursement rules ...
... Technologies Corporation (NASDAQ:DVAX) announced today that it plans to report third quarter ... , ... BERKELEY, Calif. (Business Wire EON) October 30, 2008 -- ... the Oppenheimer 19th Annual Healthcare Conference in New York City on November ...
... Breast Cancer Survivors Learn about the Importance of ... SAN DIEGO, Oct. 30 A large number ... part of the "Know Your,L-Dex" awareness campaign activities ... Houston and Dallas., (Photo: http://www.newscom.com/cgi-bin/prnh/20081030/NY43020 ...
... Conference Call Scheduled Wednesday, November 5, 2008 at 11:00 a.m.,ET ... AFAM ), a leading regional provider of home health ... third quarter,2008 ended September 30, 2008 on Wednesday, November 5, ... the results will begin at 11:00 a.m. ET on,November 5, ...
... International,Inc. (Nasdaq: DATA ), a technology and services ... industry, today announced that,it will host a conference call ... 2008 at 4:30 p.m. ET on Thursday, November 6, ... to dial 412-858-4600 a,few minutes before 4:30 p.m. ET. ...
Cached Medicine News:Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 2Health News:Gentiva(R) Health Services to Present at November Investment Conferences Hosted by Oppenheimer, Credit Suisse and Stephens 3Health News:Schering-Plough to Appeal Jury Decision in Missouri Reimbursement Case 2Health News: Dynavax to Report Third Quarter 2008 Financial Results : -- To Present at Oppenheimer's Healthcare Conference -- 2Health News:'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events 2Health News:'Know Your L-Dex(TM)' (Lymphedema Index) Awareness Campaign Attracts Large Numbers of Breast Cancer Survivors at Komen Race for the Cure(R) Events 3Health News:Almost Family, Inc. to Report Third Quarter 2008 Financial Results 2Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 2Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 3
(Date:9/19/2014)... 19, 2014 Intarcia Therapeutics, Inc. ... for its lead candidate ITCA 650 (continuous subcutaneous delivery ... baseline HbA1c levels at the 50 th Annual ... Diabetes (EASD). Data from the open-label, phase 3 FREEDOM-HBL ... sugar in patients with poorly controlled type 2 diabetes. ...
(Date:9/19/2014)... September 19, 2014 Reductions in ... many years in people with diabetes type 2 ... term benefits for the kidneys." Australian researchers ... type 2 diabetes leads to persistent reductions in kidney ... The global study has found that, five and ...
(Date:9/18/2014)... 18, 2014  Low T Center endorses the ... Hyattsville, Maryland earlier this ... proper patient population for testosterone therapy (TRT), as ... with TRT. Examining recent claims from studies that TRT ... epidemiological studies do not provide convincing evidence that ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... DEERFIELD, IL, June 04, 2007,/PRNewswire-FirstCall/ - Cardiome ... US, Inc. ("Astellas") today,announced results from their ... 2. The trial evaluated the efficacy and ... (iv)") for the treatment of patients who ...
... -- ZymoGenetics,Inc. today announced that interim findings were ... in B-cell chronic,lymphocytic leukemia (B-CLL) at the American ... study included intravenous,administration of higher doses than had ... atacicept was well-tolerated and biologically,active at all dose ...
Cached Medicine Technology:Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3
... SC Strep A is a rapid point-of-care ... Strep A antigen in throat swab specimens. ... use no mixing, measuring or working ... cassette format and clearly visible result window ...
... A Twist Rapid Test Device (Throat Swab) is ... a patented design to provide convenience to the ... swab chamber, eliminating the need for test tubes ... exhibits a 93% accuracy compared to plate culture, ...
... Since 1994 the CoaguChek System has been ... needed most, at the point of care. , ... for thousands of patients self-testing when monitoring on ... the user to obtain a result from a ...
... Ovulation Tests are qualitative immunoassays for detecting elevated ... procedure is fast and results are easy to ... is darker than the control band, then ovulation ... If the test band does not appear ...
Medicine Products: